Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-05-17
DOI
10.3389/fphar.2022.895668
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia
- (2021) Tyler R. Prestwood et al. BEHAVIOURAL BRAIN RESEARCH
- Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?
- (2021) Nikolaos Pitsikas MOLECULES
- How do established developmental risk-factors for schizophrenia change the way the brain develops?
- (2021) Darryl W. Eyles Translational Psychiatry
- Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
- (2021) Merhawi Bahta et al. Annals of General Psychiatry
- Potential role of hydroxytyrosol in neuroprotection
- (2021) Chen Chen et al. Journal of Functional Foods
- Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety
- (2021) Md. Abdul Hannan et al. Nutrients
- Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals
- (2021) Shivika Datta et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- The Impact of THC and CBD in Schizophrenia: A Systematic Review
- (2021) Saeed Ahmed et al. Frontiers in Psychiatry
- Potential Therapeutic Strategies of Phytochemicals in Neurodegenerative Disorders
- (2021) Dharmendra Kumar Yadav CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways
- (2020) Mina Y. George et al. LIFE SCIENCES
- Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
- (2020) Michelle Kokkinou et al. MOLECULAR PSYCHIATRY
- Kaempferol protects against cadmium chloride-induced hippocampal damage and memory deficits by activation of silent information regulator 1 and inhibition of poly (ADP-Ribose) polymerase-1
- (2020) Attalla Farag El-kott et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Luteolin, a Potent Human Monoamine Oxidase-A Inhibitor and Dopamine D4 and Vasopressin V1A Receptor Antagonist
- (2020) Se Eun Park et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
- (2020) Areoo Samaei et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
- (2020) María S. García-Gutiérrez et al. Biomolecules
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
- (2019) Robert A. McCutcheon et al. TRENDS IN NEUROSCIENCES
- Application of quercetin in neurological disorders: from nutrition to nanomedicine
- (2019) Elnaz Amanzadeh et al. REVIEWS IN THE NEUROSCIENCES
- A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
- (2019) C. Michael White JOURNAL OF CLINICAL PHARMACOLOGY
- Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia
- (2019) Chanoch Miodownik et al. CLINICAL NEUROPHARMACOLOGY
- Effects of the Hyptis martiusii Benth. leaf essential oil and 1,8-cineole (eucalyptol) on the central nervous system of mice
- (2019) Francisco Rodolpho Sobreira Dantas Nóbrega de Figuêiredo et al. FOOD AND CHEMICAL TOXICOLOGY
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Alterations in cortical interneurons and cognitive function in schizophrenia
- (2018) Samuel J. Dienel et al. NEUROBIOLOGY OF DISEASE
- Protective effects of stigmasterol against ketamine‐induced psychotic symptoms: Possible behavioral, biochemical and histopathological changes in mice
- (2018) Monu Yadav et al. Pharmacological Reports
- The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention
- (2018) Anthony A Grace et al. SCHIZOPHRENIA BULLETIN
- Drug repositioning for schizophrenia and depression/anxiety disorders: A machine learning approach leveraging expression data
- (2018) Kai Zhao et al. IEEE Journal of Biomedical and Health Informatics
- Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder
- (2018) Eva Z. Hoseth et al. Translational Psychiatry
- The influence of quercetin on recognition memory and brain oxidative damage in a ketamine model of schizophrenia
- (2018) Derya Guliz Mert et al. Psychiatry and Clinical Psychopharmacology
- Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia
- (2018) Zhizhong Xu et al. NEUROREPORT
- Antipsychotic-like activity of scopoletin and rutin against the positive symptoms of schizophrenia in mouse models
- (2017) Vijayapandi Pandy et al. EXPERIMENTAL ANIMALS
- Crocins, the active constituents of Crocus sativus L., counteracted apomorphine-induced performance deficits in the novel object recognition task, but not novel object location task, in rats
- (2017) Nikolaos Pitsikas et al. NEUROSCIENCE LETTERS
- Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations
- (2017) Monu Yadav et al. INFLAMMOPHARMACOLOGY
- Urinary Clearance of Cranberry Flavonol Glycosides in Humans
- (2016) Yifei Wang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Hormesis, cellular stress response and neuroinflammation in schizophrenia: Early onset versus late onset state
- (2016) Vittorio Calabrese et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study
- (2016) Gaurav Kumar et al. MEDICAL HYPOTHESES
- Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia
- (2016) Mohammed Garba Magaji et al. METABOLIC BRAIN DISEASE
- Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice
- (2016) Jen-Cheng Lin et al. PSYCHOPHARMACOLOGY
- Clinical studies of neuroinflammatory mechanisms in schizophrenia
- (2016) Crystal C. Watkins et al. SCHIZOPHRENIA RESEARCH
- The Effect ofCrocus sativusL. and Its Constituents on Memory: Basic Studies and Clinical Applications
- (2015) Nikolaos Pitsikas Evidence-based Complementary and Alternative Medicine
- A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings
- (2015) Andrea Gogos et al. International Journal of Endocrinology
- Oxidative stress: a concept in redox biology and medicine
- (2015) Helmut Sies Redox Biology
- Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
- (2014) Gerwyn Morris et al. Current Neuropharmacology
- EPA-0117 – The use of bacosides a and b to prevent a cognitive deficit in schizophrenia rat models resulting in increased vesicular glutamate transporter 2 (VGLUT2) in the cingulate gyrus
- (2014) T. Wetchateng et al. EUROPEAN PSYCHIATRY
- Mangiferin ameliorates 6-hydroxydopamineinduced cytotoxicity and oxidative stress in ketamine model of schizophrenia
- (2014) Vietla S. Rao et al. Pharmacological Reports
- Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia
- (2014) Maju Mathew Koola et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia: an integrated sociodevelopmental-cognitive model
- (2013) Oliver D Howes et al. LANCET
- The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings
- (2013) Norbert Müller et al. NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH
- Inflammation and the two-hit hypothesis of schizophrenia
- (2013) Keith A. Feigenson et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Crocins, the active constituents of Crocus Sativus L., counteracted ketamine–induced behavioural deficits in rats
- (2013) Georgia Georgiadou et al. PSYCHOPHARMACOLOGY
- NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
- (2013) Melissa A. Snyder et al. Frontiers in Cellular Neuroscience
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism
- (2012) Alan S. Brown Developmental Neurobiology
- Impaired mitochondrial function in psychiatric disorders
- (2012) Husseini Manji et al. NATURE REVIEWS NEUROSCIENCE
- Free radicals and antioxidants: updating a personal view
- (2012) Barry Halliwell NUTRITION REVIEWS
- The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
- (2012) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration
- (2012) Yumi Shirai et al. Clinical Psychopharmacology and Neuroscience
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Anti-inflammatory signaling in schizophrenia
- (2011) Urs Meyer BRAIN BEHAVIOR AND IMMUNITY
- Oxidative Stress in Schizophrenia
- (2011) Iztok Grabnar et al. Current Neuropharmacology
- Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors
- (2011) Takashi Ueda et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antipsychotic property of aqueous and ethanolic extracts of Lonchocarpus cyanescens (Schumach and Thonn.) Benth. (Fabaceae) in rodents
- (2011) Mubo A. Sonibare et al. Journal of Natural Medicines
- Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models
- (2011) M. Pereira et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
- (2010) Alan S. Brown et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia
- (2010) Eleanor H. Simpson et al. NEURON
- The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats
- (2010) Makoto Mizuno et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine
- (2010) Segev Barak et al. PSYCHOPHARMACOLOGY
- Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
- (2010) Caline S. Karam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling
- (2009) Dayong Wu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies
- (2009) David A. Lewis et al. JOURNAL OF CLINICAL INVESTIGATION
- Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
- (2009) Glenn Schwarcz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit
- (2009) Suzie Lavoie et al. JOURNAL OF NEUROCHEMISTRY
- Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor
- (2008) Teresa Tarragó et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Alzheimer's Disease Drugs: An Application of the Hormetic Dose-Response Model
- (2008) Edward J. Calabrese CRITICAL REVIEWS IN TOXICOLOGY
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- The anthraquinone derivative Emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia
- (2008) M. Mizuno et al. JOURNAL OF NEURAL TRANSMISSION
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
- Cytoprotective effects of phenolic antioxidants and essential fatty acids in human blood monocyte and neuroblastoma cell lines: Surrogates for neurological damage in vivo
- (2007) Julie Young et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started